These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 22951565)

  • 1. Why do we overtreat hypertension?
    Spence D
    BMJ; 2012 Sep; 345():e5923. PubMed ID: 22951565
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the usage of antihypertensive drugs: implications and prospects.
    Schachter M
    Br J Clin Pharmacol; 2005 Sep; 60(3):231-4. PubMed ID: 16120060
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood pressure control: time for action.
    Lantelme P
    Arch Cardiovasc Dis; 2009; 102(6-7):465-7. PubMed ID: 19664564
    [No Abstract]   [Full Text] [Related]  

  • 4. Poor blood pressure control in general practice: in search of explanations.
    Nicodème R; Albessard A; Amar J; Chamontin B; Lang T
    Arch Cardiovasc Dis; 2009; 102(6-7):477-83. PubMed ID: 19664567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hypertension in light of the new national guidelines.
    Moser M
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):12-9. PubMed ID: 12971588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage.
    Mancia G; Zanchetti A;
    J Hypertens; 2008 Feb; 26(2):164-8. PubMed ID: 18192825
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension control rates: time for translation of guidelines into clinical practice.
    Hart PD; Bakris GL
    Am J Med; 2004 Jul; 117(1):62-4. PubMed ID: 15210392
    [No Abstract]   [Full Text] [Related]  

  • 8. Overcoming therapeutic inertia in patients with hypertension.
    Nesbitt SD
    Postgrad Med; 2010 Jan; 122(1):118-24. PubMed ID: 20107295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy: the CHECK Study.
    Filippi A; Casula M; Tragni E; Brignoli O; Cricelli C; Poli A; Catapano AL;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):562-8. PubMed ID: 20308908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insufficient therapeutic management of hypertensive patients with renal failure in France.
    P-Guérin A; Maumus-Robert S; Zin A
    Arch Cardiovasc Dis; 2008; 101(11-12):705-13. PubMed ID: 19059565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influencing prescribing patterns.
    Huston P; Campbell NR
    Can Fam Physician; 1998 Feb; 44():221-3, 228-30. PubMed ID: 9512821
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing hypertension management in clinical practice.
    Heagerty A
    J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcome clinical inertia to control systolic blood pressure.
    O'Connor PJ
    Arch Intern Med; 2003 Dec 8-22; 163(22):2677-8. PubMed ID: 14662620
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
    Amira CO; Okubadejo NU
    J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent blood pressure guidelines: making sense of the controversy.
    Dennison Himmelfarb CR; Hayman LL
    J Cardiovasc Nurs; 2014 Jul; 29(4):285-7. PubMed ID: 24911105
    [No Abstract]   [Full Text] [Related]  

  • 17. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
    Gu Q; Burt VL; Paulose-Ram R; Dillon CF
    Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, double-blind, seemingly ignored clinical trials.
    Materson BJ
    Am J Hypertens; 1999 Jan; 12(1 Pt 1):76-8. PubMed ID: 10075389
    [No Abstract]   [Full Text] [Related]  

  • 19. Between-country variation in the utilization of antihypertensive agents: Guidelines and clinical practice.
    Stolk P; Van Wijk BL; Leufkens HG; Heerdink ER
    J Hum Hypertens; 2006 Dec; 20(12):917-22. PubMed ID: 16988753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice patterns in hypertension.
    Hardin B
    CMAJ; 1997 Nov; 157(10):1348-9. PubMed ID: 9371060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.